Philip S. Low

Philip S. Low

Purdue University

H-index: 122

North America-United States

About Philip S. Low

Philip S. Low, With an exceptional h-index of 122 and a recent h-index of 59 (since 2020), a distinguished researcher at Purdue University, specializes in the field of Targeted drug delivery, fluorescence guided surgery, radioligand therapy, folate receptor, immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

In Vivo Labeling and Detection of Circulating Tumor Cells in Mice Using OTL38

Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof

Methods, compounds, and compositions for modifying car-t cell activity

Discovery of a cebrelon-based PTPN1/PTPN2 dual targeting degrader for cancer immunotherapy

Fibroblast activation protein (fap)-targeted antifibrotic therapy

Folate receptor-targeted conjugates, compositions, and delivery to the central nervous system

Prospects for fluorescence molecular in vivo liquid biopsy of circulating tumor cells

Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment

Philip S. Low Information

University

Purdue University

Position

Professor of Chemistry

Citations(all)

71963

Citations(since 2020)

20702

Cited By

49981

hIndex(all)

122

hIndex(since 2020)

59

i10Index(all)

486

i10Index(since 2020)

313

Email

University Profile Page

Purdue University

Philip S. Low Skills & Research Interests

Targeted drug delivery

fluorescence guided surgery

radioligand therapy

folate receptor

immunotherapy

Top articles of Philip S. Low

Title

Journal

Author(s)

Publication Date

In Vivo Labeling and Detection of Circulating Tumor Cells in Mice Using OTL38

Molecular Imaging and Biology

Joshua Pace

Jane J Lee

Madduri Srinivasarao

Shivakrishna Kallepu

Philip S Low

...

2024/4/9

Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof

2024/1/30

Methods, compounds, and compositions for modifying car-t cell activity

2024/2/22

Discovery of a cebrelon-based PTPN1/PTPN2 dual targeting degrader for cancer immunotherapy

Cancer Research

Zihan Qu

Yunpeng Bai

Jiajun Dong

Zheng Zhang

Bo Huang

...

2024/3/22

Fibroblast activation protein (fap)-targeted antifibrotic therapy

2024/1/4

Folate receptor-targeted conjugates, compositions, and delivery to the central nervous system

2024/2/22

Prospects for fluorescence molecular in vivo liquid biopsy of circulating tumor cells

Frontiers in Photonics

Mark Niedre

2022/5/9

Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment

Frontiers in Immunology

Fenghua Zhang

Bo Huang

Sagar M Utturkar

Weichuan Luo

Gregory Cresswell

...

2024/2/7

Targeted Delivery of Abaloparatide to Spinal Fusion Site Accelerates Fusion Process in Rats

Biomedicines

Jeffery J Nielsen

Stewart A Low

Christopher Chen

Xinlan Li

Ephraim Mbachu

...

2024/3/8

Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis

2024/2/6

Methods of use for car t cells

2023/10/10

Methods for treating hemolytic diseases and sickle cell disease

2023/1/19

Molecular Imaging in Precision-Cut Non-Small Cell Lung Cancer Slices

The Annals of Thoracic Surgery

Feredun Azari

Gregory T Kennedy

Ashley Chang

Philip Low

Maria Basil

...

2024/2/1

Histology and Lung Nodule Fluorescence in Intraoperative Molecular Imaging with Pafolacianine

Annals of Thoracic Surgery Short Reports

Patrick Bou-Samra

Austin Chang

Emily Guo

Feredun Azari

Gregory Kennedy

...

2024/3/5

Syk kinase inhibitors as treatment for malaria

2023/4/27

A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy

Oncogene

Ahmed M Abdelaal

Ikjot S Sohal

Shreyas Iyer

Kasireddy Sudarshan

Harish Kothandaraman

...

2023/9/29

Pi3 kinase inhibitors and uses thereof

2023/5/25

Water-soluble chromenylium dyes for shortwave infrared imaging in mice

Chem

Shang Jia

Eric Y Lin

Emily B Mobley

Irene Lim

Lei Guo

...

2023/12/14

Imaging Activated Macrophage Localization Using A Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent In Injured Knees

Osteoarthritis and Cartilage

H Willcockson

H Ozkan

JE Frank

H Yuan

MD Williams

...

2023/3/1

Fluorescent Molecular Labeling and In Vivo Detection of Circulating Tumor Cells in Mice

Joshua Pace

Srinivasarao Madduri

Shivakrishna Kallepu

Philip S Low

Mark Niedre

2023/4/24

See List of Professors in Philip S. Low University(Purdue University)

Philip S. Low FAQs

What is Philip S. Low's h-index at Purdue University?

The h-index of Philip S. Low has been 59 since 2020 and 122 in total.

What are Philip S. Low's top articles?

The articles with the titles of

In Vivo Labeling and Detection of Circulating Tumor Cells in Mice Using OTL38

Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof

Methods, compounds, and compositions for modifying car-t cell activity

Discovery of a cebrelon-based PTPN1/PTPN2 dual targeting degrader for cancer immunotherapy

Fibroblast activation protein (fap)-targeted antifibrotic therapy

Folate receptor-targeted conjugates, compositions, and delivery to the central nervous system

Prospects for fluorescence molecular in vivo liquid biopsy of circulating tumor cells

Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment

...

are the top articles of Philip S. Low at Purdue University.

What are Philip S. Low's research interests?

The research interests of Philip S. Low are: Targeted drug delivery, fluorescence guided surgery, radioligand therapy, folate receptor, immunotherapy

What is Philip S. Low's total number of citations?

Philip S. Low has 71,963 citations in total.